pharma
Senescent cell findings provides Parkinson’s treatment clue
January 25, 2018Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical
Senescent cells are the dormant state that cells shift to in response to certain stressors, it is thought that they …
Spark hands over Luxturna rights outside US to Novartis for $170m
January 25, 2018Sales and Marketing Luxturna, Novartis, Spark Therapeutics, pharma
Novartis has confirmed a deal worth a potential $170 million with Spark Therapeutics to develop and commercialise its gene therapy …
Amyloid pathway doubts after latest Alzheimer’s failure
January 25, 2018Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical
There has been another drug failure in a large Phase 3 that once again crushes a hope for a possible …
Trump nominee and ex-Lilly exec confirmed as US Health Secretary by Senate
January 25, 2018Manufacturing and Production, Medical Communications, Sales and Marketing Alex Azar, Eli Lilly, President trump, Trump, US, pharma
Alex Azar, President’s Trump’s controversial pick for Health and Human Services Secretary (HHS), has been confirmed in the role after …
GW Pharma boasts new positive data, readying for approval
January 25, 2018Research and Development GW Pharma, biotech, drugs, pharma, pharmaceutical
The latest data from GW Pharma is about as conclusively positive as you can usually hope to get with a …
New vaccine provides universal protection against influenza A, study finds
January 24, 2018Research and Development Georgia State University, Vaccine, flu, influenza, pharma
Research led by Georgia State University has enabled the development of a universal vaccine for influenza A viruses, proven to …
US court upholds ruling that J&J’s Remicade patent is invalid
January 24, 2018Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, Remicade, biosimilars, infliximab, patent, pharma
The US Court of Appeals for the Federal Circuit has judged that Johnson & Johnson’s patent for its best-selling arthritis …
New York City launches $500 million lawsuit against big pharma over opioid crisis
January 24, 2018Research and Development, Sales and Marketing New York City, opioid crisis, opioids, pharma
The administration of New York City Mayor Bill de Blasio has announced its intention to bring legal action against the …
Eli Lilly’s Taltz get EU approval in psoriatic arthritis subgroup
January 24, 2018Research and Development, Sales and Marketing EU, Eli Lilly, Europe, European Commission, Taltz, pharma, psoriatic arthritis
Eli Lilly has revealed that its IgG4 monoclonal antibody Taltz (ixekizumab) has been awarded marketing approval from the European Commission …
NICE recommends for online and mobile depression programme for trial on NHS
January 24, 2018Research and Development Deprexis, NHS, NICE, app, depression, pharma
NICE has said that a new online and mobile app should be trialled on the NHS in the treatment of …
J&J withdraws controversial vaginal mesh from Australian market
January 23, 2018Manufacturing and Production, Sales and Marketing J&J, JJ, Johnson & Johnson, lawsuit, pharma, vaginal mesh
Johnson & Johnson has withdrawn its controversial vaginal mesh product from the Australian market after missing a deadline requiring all …
GSK wins case against Reckitt Benckiser over misleading ad campaign
January 23, 2018Manufacturing and Production, Sales and Marketing GSK, GlaxoSmithKline, Nurofen, Panadol, Reckitt Benckiser, ibuprofen, paracetamol, pharma
GlaxoSmithKline is celebrating as it emerges that the UK pharma giant triumphed in its legal battle against Reckitt Benckiser after …
More woes for Teva as two late-stage asthma studies bomb
January 23, 2018Manufacturing and Production, Research and Development Teva, asthma, pharma
In yet more bad news for Teva, it has emerged that two of the firm’s late-stage studies in asthma have …
Bristol-Myers Squibb’s Yervoy scores EU approval in paediatric melanoma
January 23, 2018Manufacturing and Production, Sales and Marketing BMS, Bristol-Myers Squibb, EU, Yervoy, pharma
Bristol-Myers Squibb has revealed that its immunotherapy Yervoy (ipilimumab) has received an expanded indication from the European Commission, approving the …
Celgene confirms rumours, with $9bn deal for Juno
January 22, 2018Manufacturing and Production, Sales and Marketing CAR-T, Celgene, biotech, drugs, juno therapeutics, pharma, pharmaceutical
It seems like 2018 may well be the year for M&A that everyone had expected, as two major deals on …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
